MYELOSUPPRESSION AFTER METHOTREXATE, MITOXANTRONE, AND MITOMYCIN-C COMBINATION CHEMOTHERAPY

被引：0

|

作者：

POWLES, TJ

ASHLEY, S

机构：

来源：

LANCET | 1987年 / 2卷 / 8563期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：853 / 853

页数：1

相关论文

共 50 条

[21] ADJUVANT CHEMOTHERAPY WITH MITOMYCIN-C, AND WITH A MULTI-DRUG COMBINATION OF MITOMYCIN-C, 5-FLUOROURACIL AND CYTOSINE-ARABINOSIDE AFTER CURATIVE RESECTION OF GASTRIC-CANCER
NAKAJIMA, T
FUKAMI, A
TAKAGI, K
KAJITANI, T
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1980, 10 (02) : 187 - 194
[22] MITOMYCIN-C AND MITOXANTRONE CHEMOTHERAPY FOR ADVANCED BREAST-CANCER - EFFICACY WITH MINIMAL GASTROINTESTINAL TOXICITY AND ALOPECIA
PANASCI, L
SHENOUDA, G
BEGIN, L
POLLAK, M
REINKE, A
MARGOLESE, R
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1990, 26 (06) : 457 - 460
[23] Topical mitomycin-C chemotherapy for conjunctival melanoma
Czechonska, G
Finger, PT
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1996, 37 (03) : 1103 - 1103
[24] IMMUNOLOGICAL THROMBOPENIC PURPURA UNDER CHEMOTHERAPY ASSOCIATING VEHEM-26, MITOMYCIN-C AND METHOTREXATE
DESABLENS, B
TRAULLE, C
CLAISSE, JF
NEVEU, JP
DIEVAL, J
JAISSON, F
MESSERSCHMITT, J
NOUVELLE REVUE FRANCAISE D HEMATOLOGIE, 1983, 25 (03): : 211 - 211
[25] COMBINATION CHEMOTHERAPY IN METASTATIC TUMORS OF UNKNOWN ORIGIN - 5-FLUOROURACIL, ADRIAMYCIN AND MITOMYCIN-C FOR ADENOCARCINOMAS AND ADRIAMYCIN, VINBLASTINE AND MITOMYCIN-C FOR ANAPLASTIC CARCINOMAS
SULKES, A
UZIELY, B
ISACSON, R
BRUFMAN, G
BIRAN, S
ISRAEL JOURNAL OF MEDICAL SCIENCES, 1988, 24 (9-10): : 604 - 610
[26] COMBINATION TREATMENT WITH MITOMYCIN-C AND PYRIDOXINE HYDROCHLORIDE
BRADNER, WT
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1972, 13 (MAR): : 22 - &
[27] ADRIAMYCIN (DOXORUBICIN), VINBLASTINE, AND MITOMYCIN-C COMBINATION CHEMOTHERAPY IN REFRACTORY BREAST-CARCINOMA
LUIKART, SD
WITMAN, GB
PORTLOCK, CS
CANCER, 1984, 54 (07) : 1252 - 1255
[28] COMBINATION CHEMOTHERAPY OF GASTRIC CANCER WITH FLUORO-URACIL, ADRIAMYCIN AND MITOMYCIN-C (FAM)
SCHEIN, PS
CANCER IMMUNOLOGY IMMUNOTHERAPY, 1977, 3 : S29 - S29
[29] THE DIFFERENCE IN PHARMACOKINETICS OF MITOMYCIN-C, GIVEN EITHER AS A SINGLE AGENT OR AS A PART OF COMBINATION CHEMOTHERAPY
VERWEIJ, J
STUURMAN, M
DEVRIES, J
PINEDO, HM
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1986, 112 (03) : 283 - 284
[30] CHEMOTHERAPY OF EXOCRINE PANCREATIC-CARCINOMA WITH COMBINATION OF 5-FLUOROURACIL + MITOMYCIN-C
KLAPDOR, J
KLAPDOR, R
HIRSCHMANN, M
GUTHOFF, A
ROTHE, B
DIGESTIVE DISEASES AND SCIENCES, 1987, 32 (10) : 1172 - 1172

← 1 2 3 4 5 →